These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26800774)

  • 1. Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study).
    Witberg G; Ayers CR; Turer AT; Lev E; Kornowski R; de Lemos J; Neeland IJ
    Am J Cardiol; 2016 Feb; 117(4):574-579. PubMed ID: 26800774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke.
    Tu WJ; Qiu HC; Liu YK; Liu Q; Zeng X; Zhao J
    Cardiovasc Diabetol; 2020 Aug; 19(1):125. PubMed ID: 32771014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    Owens CD; Kim JM; Hevelone ND; Hamdan A; Raffetto JD; Creager MA; Conte MS
    J Vasc Surg; 2010 May; 51(5):1152-9. PubMed ID: 20223619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
    Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease.
    Urbonaviciene G; Frystyk J; Flyvbjerg A; Henneberg EW; Lindholt JS
    Atherosclerosis; 2010 Jun; 210(2):619-24. PubMed ID: 20096841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial.
    Bergmark BA; Cannon CP; White WB; Jarolim P; Liu Y; Bonaca MP; Zannad F; Morrow DA
    Diabetes Obes Metab; 2017 Jul; 19(7):962-969. PubMed ID: 28195387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study).
    Lindberg S; Mogelvang R; Pedersen SH; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2013 Apr; 111(8):1139-45. PubMed ID: 23375598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin, type 2 diabetes and cardiovascular risk.
    Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Galatius S; Jeppesen J; Mogelvang R
    Eur J Prev Cardiol; 2015 Mar; 22(3):276-83. PubMed ID: 24265290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
    von Scholten BJ; Reinhard H; Hansen TW; Oellgaard J; Parving HH; Jacobsen PK; Rossing P
    Diabetologia; 2016 Jul; 59(7):1549-1557. PubMed ID: 27033561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Angiopoietin-Like Protein 2 Is a Novel Risk Factor for Cardiovascular Disease in the Community: The Hisayama Study.
    Hata J; Mukai N; Nagata M; Ohara T; Yoshida D; Kishimoto H; Shibata M; Hirakawa Y; Endo M; Ago T; Kitazono T; Oike Y; Kiyohara Y; Ninomiya T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1686-91. PubMed ID: 27365403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary total antioxidant capacity is inversely associated with all-cause and cardiovascular disease death of US adults.
    Kim K; Vance TM; Chen MH; Chun OK
    Eur J Nutr; 2018 Oct; 57(7):2469-2476. PubMed ID: 28791462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study.
    Srinath R; Hill Golden S; Carson KA; Dobs A
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1602-8. PubMed ID: 25584720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.
    Liu G; Ding M; Chiuve SE; Rimm EB; Franks PW; Meigs JB; Hu FB; Sun Q
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2259-2267. PubMed ID: 27609367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ignorance of cardiovascular preventive measures is associated with all-cause and cardiovascular mortality in the French general population.
    Séguro F; Taraszkiewicz D; Bongard V; Bérard E; Bouisset F; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2016; 109(8-9):486-93. PubMed ID: 27342804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.